This is a preview of subscription content, log in via an institution to check access.
Notes
The preparation of the manuscript was funded by Otto Bock HealthCare Products GmbH, Austria, the manufacturer of the microprocessor-controlled knee C-Leg.
Reference
Kuhlmann A, et al. Cost-effectiveness and budget impact of the microprocessor-controlled knee C-Leg in transfemoral amputees with and without diabetes mellitus. European Journal of Health Economics : 2 Jan 2020. Available from: URL: https://doi.org/10.1007/s10198-019-01138-y
Rights and permissions
About this article
Cite this article
Microprocessor-controlled knee joints in amputees worth its cost. PharmacoEcon Outcomes News 845, 19 (2020). https://doi.org/10.1007/s40274-020-6522-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6522-1